Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FEARCON: Sertraline in OCD
NCT03068429Phase 4Completed
- Sponsor
- Universidade de São Paulo
- Start
- Dec 2016
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sertraline in obsessive compulsive disorder (OCD), sponsored by Universidade de São Paulo. Started Dec 2016; status: completed.
02
Drugs
sertraline
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT03068429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03068429.